Gene variation linked to cervical cancerBMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7145.1625h (Published 30 May 1998) Cite this as: BMJ 1998;316:1625
- Hilary Bower
Research suggesting that genetic susceptibility raises the risk of developing cervical cancer could help increase the effectiveness of cytology screening programmes.
An international collaboration group of British, Italian, and Canadian scientists has discovered that women who carry a particular variation of the tumour suppressor gene p53 are seven times more likely to develop cervical cancer than those who do not (Nature 1998; 393:229-33).
Research leader, Dr Alan Storey from the skin tumour laboratory of the Imperial Cancer Research Fund in London, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial